Mr. Rivard discusses the significance of the Federal Circuit’s decision in Association for Molecular Pathology v. USPTO for the biotech industry in a Chemical & Engineering News article titled “Patenting Human Genes,” and a BNA article titled “Patent Community Sees Post-Myriad Issues; Expects Either En Banc or High Court Review.”
Posted: August 3, 2011
